RSLS News and Press, ReShape Lifesciences Inc. From 04/12/23

2023-04-12 10:03:10 ET Gainers: Altamira Therapeutics ( CYTO ) +74% . Arrowhead Pharmaceuticals ( ARWR ) +11% . Procaps Group ( PROC ) +11% . Tempest Therapeutics ( TPST ) +11% . Meihua International Medical Technologies ( MHUA )...

2023-04-12 08:39:03 ET Brenmiller Energy ( BNRG ) -19% . GlucoTrack ( GCTK ) -16% . Innovative Eyewear ( LUCY ) -16% files patent For chatGPT enabled smart eyewear. Nouveau Monde Graphite NMG -14% launches stock offering to raise $22M. C...

2023-04-11 09:30:29 ET Innovative Eyewear ( LUCY ) +129% on launching the first ChatGPT enabled smart eyewear. ZeroFox Holdings ( ZFOX ) +63% on partnering with Google Cloud to disrupt phishing attacks and malicious URLs.WW International WW +38% as Sequence deal closes, Goldman move...

SAN CLEMENTE, Calif., April 11, 2023 (GLOBE NEWSWIRE) -- ReShape Lifesciences ™ (Nasdaq: RSLS), the premier physician-led weight loss and metabolic health solutions company, today announced that the company has received a Notice of Allowance from the U.S. Patent and Trademark O...

2023-04-03 12:52:16 ET When searching for penny stocks to buy or watch, it’s important to focus on catalysts. Penny stocks , which are stocks priced under $5 per share, often attract small and new investors. However, investing in these stocks comes with inherent risks. So it ...

2023-03-29 08:58:42 ET ReShape Lifesciences ( NASDAQ: RSLS ) announced on Tuesday that it will delay its year full year 2022 earnings release. The company needs additional time to complete its year end audited financial information. It will announce a new date for the rele...

2023-03-29 08:23:45 ET Draganfly DPRO -17% on proposed securities offering . SomaLogic SLGC -15% on Q4 earnings release . Shift Technologies SFT -15% on Q4 earnings release . Sharecare SHCR -12% on Q4 earnings release . Allarity Therapeu...

SAN CLEMENTE, Calif., March 28, 2023 (GLOBE NEWSWIRE) -- ReShape Lifesciences Inc. (Nasdaq: RSLS), the premier physician-led weight loss and metabolic health-solutions company, today announced that it will delay its year ended December 31, 2022 earnings release and conference call, pr...

SAN CLEMENTE, Calif., March 23, 2023 (GLOBE NEWSWIRE) -- ReShape Lifesciences Inc. (Nasdaq: RSLS), the premier physician-led weight loss and metabolic health-solutions company, today announced the formation of a Scientific Advisory Board (SAB). Members include internationally reco...

SAN CLEMENTE, Calif., March 22, 2023 (GLOBE NEWSWIRE) -- ReShape Lifesciences Inc. (Nasdaq: RSLS), the premier physician-led weight loss and metabolic health-solutions company, today announced that it will report its financial results for the year ended December 31, 2022, including a ...